Foresee Pharmaceuticals Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 301.51 million compared to TWD 226.03 million a year ago. Net loss was TWD 472.64 million compared to TWD 569.27 million a year ago.

Basic loss per share from continuing operations was TWD 4 compared to TWD 4.85 a year ago. Diluted loss per share from continuing operations was TWD 4 compared to TWD 4.85 a year ago.